|
2.1108 %
| NASDAQ | US74838J1016 | QDEL-US | Quidel Corporation |
1
|
|
1.9191 %
| NASDAQ | US8523123052 | STAA-US | STAAR Surgical Company |
2
|
|
1.8114 %
| NASDAQ | US88025U1097 | TXG-US | 10x Genomics Inc Class A |
3
|
|
1.7847 %
| NASDAQ | US81181C1045 | SGEN-US | Seagen Inc |
4
|
|
1.7367 %
| NASDAQ | US5895841014 | VIVO-US | Meridian Bioscience, Inc. |
5
|
|
1.7014 %
| NASDAQ | US00653Q1022 | AHCO-US | AdaptHealth Corp. Class A |
6
|
|
1.6828 %
| NASDAQ | US7438151026 | PRSC-US | Providence Service Corporation |
7
|
|
1.5943 %
| NYSE | US92857F1075 | VCRA-US | Vocera Communications, Inc. |
8
|
|
1.5911 %
| NASDAQ | US7599161095 | RGEN-US | Repligen Corporation |
9
|
|
1.5857 %
| NASDAQ | US45784P1012 | PODD-US | Insulet Corporation |
10
|
|
1.5561 %
| NYSE | US0905722072 | BIO-US | Bio-Rad Laboratories, Inc. Class A |
11
|
|
1.5523 %
| NYSE | US2358511028 | DHR-US | Danaher Corporation |
12
|
|
1.5400 %
| NYSE | US8835561023 | TMO-US | Thermo Fisher Scientific Inc. |
13
|
|
1.5252 %
| NASDAQ | US45168D1046 | IDXX-US | IDEXX Laboratories, Inc. |
14
|
|
1.5229 %
| NASDAQ | US4364401012 | HOLX-US | Hologic, Inc. |
15
|
|
1.5192 %
| NASDAQ | US91307C1027 | UTHR-US | United Therapeutics Corporation |
16
|
|
1.5180 %
| NASDAQ | US8292141053 | SLP-US | Simulations Plus, Inc. |
17
|
|
1.5078 %
| NYSE | US1598641074 | CRL-US | Charles River Laboratories International, Inc. |
18
|
|
1.4999 %
| NASDAQ | US67020Y1001 | NUAN-US | Nuance Communications, Inc. |
19
|
|
1.4826 %
| NYSE | US1488061029 | CTLT-US | Catalent Inc |
20
|
|
1.4757 %
| NASDAQ | US5747951003 | MASI-US | Masimo Corporation |
21
|
|
1.4750 %
| NASDAQ | US1710774076 | CDXC-US | ChromaDex Corporation |
22
|
|
1.4730 %
| NYSE | US9224751084 | VEEV-US | Veeva Systems Inc Class A |
23
|
|
1.4724 %
| NYSE | US87918A1051 | TDOC-US | Teladoc Health, Inc. |
24
|
|
1.4642 %
| NYSE | US5926881054 | MTD-US | Mettler-Toledo International Inc. |
25
|
|
1.4617 %
| NASDAQ | US40637H1095 | HALO-US | Halozyme Therapeutics, Inc. |
26
|
|
1.4580 %
| NYSE | US00846U1016 | A-US | Agilent Technologies, Inc. |
27
|
|
1.4574 %
| NYSE | US90328M1071 | USNA-US | USANA Health Sciences, Inc. |
28
|
|
1.4539 %
| NYSE | US7140461093 | PKI-US | PerkinElmer, Inc. |
29
|
|
1.4530 %
| NYSE | US9553061055 | WST-US | West Pharmaceutical Services, Inc. |
30
|
|
1.4496 %
| NASDAQ | US50187A1079 | LHCG-US | LHC Group, Inc. |
31
|
|
1.4453 %
| NASDAQ | US0234361089 | AMED-US | Amedisys, Inc. |
32
|
|
1.4321 %
| NASDAQ | US09073M1045 | TECH-US | Bio-Techne Corporation |
33
|
|
1.4318 %
| NYSE | US70975L1070 | PEN-US | Penumbra, Inc. |
34
|
|
1.4306 %
| NYSE | NL0012169213 | QGEN-US | QIAGEN NV |
35
|
|
1.4199 %
| NASDAQ | US30161Q1040 | EXEL-US | Exelixis, Inc. |
36
|
|
1.4046 %
| NYSE | US9418481035 | WAT-US | Waters Corporation |
37
|
|
1.3985 %
| NASDAQ | IE00BQPVQZ61 | HZNP-US | Horizon Therapeutics Public Limited Company |
38
|
|
1.3905 %
| NASDAQ | US8753722037 | TNDM-US | Tandem Diabetes Care, Inc. |
39
|
|
1.3901 %
| NYSE | US7611521078 | RMD-US | ResMed Inc. |
40
|
|
1.3825 %
| NASDAQ | US4500561067 | IRTC-US | iRhythm Technologies, Inc. |
41
|
|
1.3807 %
| NYSE | US98978V1035 | ZTS-US | Zoetis, Inc. Class A |
42
|
|
1.3698 %
| NYSE | US0028241000 | ABT-US | Abbott Laboratories |
43
|
|
1.3651 %
| NASDAQ | US14843C1053 | CSTL-US | Castle Biosciences, Inc. |
44
|
|
1.3591 %
| NYSE | US4577301090 | INSP-US | Inspire Medical Systems, Inc. |
45
|
|
1.3572 %
| NASDAQ | US1567821046 | CERN-US | Cerner Corporation |
46
|
|
1.3453 %
| NYSE | US28176E1082 | EW-US | Edwards Lifesciences Corporation |
47
|
|
1.3423 %
| NASDAQ | US7033951036 | PDCO-US | Patterson Companies, Inc. |
48
|
|
1.3344 %
| NASDAQ | US46120E6023 | ISRG-US | Intuitive Surgical, Inc. |
49
|
|
1.3308 %
| NASDAQ | US0036541003 | ABMD-US | ABIOMED, Inc. |
50
|
|
1.3284 %
| NASDAQ | US75886F1075 | REGN-US | Regeneron Pharmaceuticals, Inc. |
51
|
|
1.3188 %
| NASDAQ | US45337C1027 | INCY-US | Incyte Corporation |
52
|
|
1.3158 %
| NYSE | US6075251024 | MODN-US | Model N, Inc. |
53
|
|
1.3117 %
| NASDAQ | US2521311074 | DXCM-US | DexCom, Inc. |
54
|
|
1.3108 %
| NYSE | US16359R1032 | CHE-US | Chemed Corporation |
55
|
|
1.3047 %
| NYSE | US4781601046 | JNJ-US | Johnson & Johnson |
56
|
|
1.3000 %
| NASDAQ | US3723091043 | GNMK-US | GenMark Diagnostics, Inc. |
57
|
|
1.2921 %
| NASDAQ | US8688731004 | SRDX-US | Surmodics Inc |
58
|
|
1.2891 %
| NASDAQ | US58506Q1094 | MEDP-US | Medpace Holdings, Inc. |
59
|
|
1.2612 %
| NYSE | US5324571083 | LLY-US | Eli Lilly and Company |
60
|
|
1.2504 %
| NASDAQ | US4523271090 | ILMN-US | Illumina, Inc. |
61
|
|
1.2416 %
| NASDAQ | US0311621009 | AMGN-US | Amgen Inc. |
62
|
|
1.2336 %
| NYSE | US58933Y1055 | MRK-US | Merck & Co., Inc. |
63
|
|
1.2153 %
| NYSE | US00287Y1091 | ABBV-US | AbbVie, Inc. |
64
|
|
1.2058 %
| NASDAQ | US6951271005 | PCRX-US | Pacira Pharmaceuticals, Inc. |
65
|
|
1.1960 %
| NYSE | US29089Q1058 | EBS-US | Emergent BioSolutions Inc. |
66
|
|
1.1726 %
| NASDAQ | US64125C1099 | NBIX-US | Neurocrine Biosciences, Inc. |
67
|
|
1.1232 %
| NASDAQ | US6833731044 | OTRK-US | Ontrak, Inc. |
68
|
|
1.1137 %
| NYSE AMERICAN | US2854091087 | ELMD-US | Electromed, Inc. |
69
|
|
1.0683 %
| NASDAQ | US92532F1003 | VRTX-US | Vertex Pharmaceuticals Incorporated |
70
|
